at least 9,000 rohingya were killed in rakhine state from august 25 to september 24, according to doctors without borders..
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
18 may, 2018, 09:28 | author: denise dawson.
. "the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology..
the longest one patient waited for treatment following a gp referral in 2017 was 541 days - against a target of 62 days...